Announcement

Collapse
No announcement yet.

Research Articles Abstracts?May 12 2014 Issue

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    Research Articles Abstracts?May 12 2014 Issue

    [Source: AMEDEO, homepage: (LINK).]


    Research Articles Abstracts?May 12 2014 Issue
    _____

    This week?s Abstracts:
    __
    • Antiviral Res
      • MAK TM, Hanson BJ, Tan YJ
        • Chimerization and characterization of a monoclonal antibody with potent neutralizing activity across multiple influenza A H5N1 clades.

      • JANG YJ, Achary R, Lee HW, Lee HJ, et al
        • Synthesis and anti-influenza virus activity of 4-oxo- or thioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-ones.

    • Arch Virol
      • CHEN J, Fu X, Chen Y, He S, et al
        • Identification of four genotypes of H3N2 swine influenza virus in pigs from southern China.

    • Biochem Biophys Res Commun
      • KIM JI, Hwang MW, Lee I, Park S, et al
        • The PDZ-binding motif of the avian NS1 protein affects transmission of the 2009 influenza A(H1N1) virus.

    • BMJ
      • JEFFERSON T, Jones M, Doshi P, Spencer EA, et al
        • Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

      • HENEGHAN CJ, Onakpoya I, Thompson M, Spencer EA, et al
        • Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

      • KRUMHOLZ HM

    • J Infect Dis
      • ESCURET V, Collins PJ, Casalegno JS, Vachieri SG, et al
        • A novel I221 L substitution in neuraminidase confers high level resistance to oseltamivir in influenza B viruses.

    • J Virol
      • MATSUOKA Y, Suguitan A Jr, Orandle M, Paskel M, et al
        • African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.

      • UNGER BL, Ganesan S, Comstock AT, Faris AN, et al
        • Nod-like receptor X-1 is required for rhinovirus-induced barrier dysfunction in airway epithelial cells.

    • J Virol Methods
      • NAKAUCHI M, Takayama I, Takahashi H, Oba K, et al
        • Real-time RT-PCR Assays for Discriminating Influenza B Virus Yamagata and Victoria Lineages.

      • BANIASADI V, Lal SK
        • A novel method to produce Influenza A virus matrix protein M1 Capsid Like Particles (CLPs).

    • N Engl J Med
    • PLoS One
      • ARILAHTI V, Makela SM, Tynell J, Julkunen I, et al
        • Novel Avian Influenza A (H7N9) Virus Induces Impaired Interferon Responses in Human Dendritic Cells.

      • WU S, Liu ZP, Qiu X, Wu H, et al
        • Modeling genome-wide dynamic regulatory network in mouse lungs with influenza infection using high-dimensional ordinary differential equations.

    • Proc Natl Acad Sci U S A
      • JAWORSKA J, Coulombe F, Downey J, Tzelepis F, et al
        • NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein.

    • Vaccine
      • HEGDE NR, Kumar D, Rao PP, Kumari KK, et al
        • Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India.

      • BLOM H, Akerblom A, Kon T, Shaker S, et al
        • Efficient chromatographic reduction of ovalbumin for egg-based influenza virus purification.

      • ROULEAU I, De Serres G, Skowronski DM, Drolet JP, et al
        • Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada.

      • HUY CD, Sakoda Y, Nishi T, Hiono T, et al
        • Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9).

      • ZIMMERMAN RK, Nowalk MP, Lin CJ, Hannibal K, et al
        • Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care.

      • WIBOWO N, Hughes FK, Fairmaid EJ, Lua LH, et al
        • Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: Extending the potential of broadly cross-protecting epitopes.

    -
    ------
    Tags: None
Previous template Next
Working...
X